Postcode lottery of care persists in England
September 11, 2008Sales and Marketing par
A new report identifies widespread variations in how much the NHS spends locally on different diseases. The King's Fund says …
Oxford BioMedica unsettled by chief executive’s departure
September 10, 2008Sales and Marketing Oxford BioMedica, biotech
Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …
Viehbacher leaves GSK for Sanofi
September 10, 2008Sales and Marketing GSK, Sanofi
Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …
Government looks set to allow top-up fees
September 10, 2008Sales and Marketing Cancer, Karol Sikora, NICE
Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …
Tapping into the audience’s imagination
September 9, 2008Medical Communications Best of Health, IPA, advertising, awards, event
Latest news from Datamonitor
September 9, 2008Sales and Marketing lifecycle
Drug lifecycle management could be the answer to the $100 billion questionGenerics are finding their way onto the drugs market …
European research centres unite to battle cancer
September 9, 2008Research and Development Cancer, EU, France, Netherlands, Sweden
Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Pfizer to co-market new Alzheimer’s drug
September 5, 2008Sales and Marketing Alzheimer's, Pfizer
Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …
Experts play down Inergy cancer risk
September 5, 2008Sales and Marketing Merck, cv
Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …
Latest news from Datamonitor
September 4, 2008Research and Development Alzheimer's
Attention shifts from beta-amyloid to tau in the hunt for an Alzheimer's disease therapyIn years to come, scientists and pharmaceutical …
Living with the Code of Practice
September 4, 2008Medical Communications, Sales and Marketing ABPI, UK, code, marketing, pharma
The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …
The Pharmafocus Interview: Martin Dawkins
September 4, 2008Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare
Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
Roche named and shamed for Code breaches
September 2, 2008Sales and Marketing ABPI, ethics
Roche has been named and shamed in the medical press for breaching the ABPI's Code of Practice. Adverts about the …
Latest news from Datamonitor
September 1, 2008Research and Development Pfizer
Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …
North West to pilot first regional allergy centre
September 1, 2008NHS, hc
The first of a new kind of NHS allergy centre will be developed by North West SHA as part of …
Scottish schools first to deliver new cancer jab
September 1, 2008Sales and Marketing Scotland, vaccines
Scotland's secondary schools will this week become the first in the UK to vaccinate female students against cervical cancer. It …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
